Please be informed that the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) is introducing electronic delivery of issued documents through the new system for […]

On 22 January 2026, Zagreb, Croatia, once again became a meeting point for regulatory collaboration as the IncreaseNET 2026 Innovation Symposium: Bridging Innovation and Regulation brought together 134 participants, both […]

The updated EURIPID Guidance Document on External Reference Pricing (ERP) provides practical, evidence-based insights for policymakers across Europe. A key milestone of the EURIPID ACCESS project has been the update […]

JAMS 2.0 project aims to reinforce the market surveillance of medical devices (MD) and in-vitro medical devices (IVD) in EU/EEA Member States to harmonize approaches in this field across the […]

JAZMP is ambitious to further actively participate in assessment of marketing authorisation applications. In order to strengthen Slovenia’s position in the regulatory EU environment, one of the strategic objectives of […]

The joint HMA-EMA Network Data Steering Group (NDSG) is running an EU survey to inform research priorities for AI use in the development and evaluation of medicines. To access the […]

The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) will host a multi-stakeholder workshop on artificial intelligence (AI) on 20 and 21 November 2025. The workshop has […]

The Accelerating Clinical Trials (ACT EU)  initiative aims to identify gaps, issues and bottlenecks (regulatory, resourcing, operational) that prevent non-commercial sponsors from setting up and conducting clinical trials and multinational […]

The Accelerating Clinical Trials in the EU (ACT EU) initiative will hold its annual Multi-Stakeholder Platform meeting on 29 October 2025. The event, organised by EMA, will gather regulators, academia, […]

As part of the Joint Action “Supporting the increased capacity and competence building of the EU medicines regulatory network” (IncreaseNET), funded under the EU4Health programme 2021–2027, the Italian Medicines Agency […]

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), as the leader of Work Package 4 Sustainability within the EU4Health joint action Reinforced Market Surveillance of […]

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) hosted members of the European Integrated Price Information Database (EURIPID) on May 13 and 14, 2025. The […]

Since February 2020, the EU Innovation Network (EU-IN) has been running a pilot project for simultaneous national scientific advice (SNSA) from national competent authorities (NCAs). SNSA specifically targets scenarios where […]

Since its launch on January 1, 2024, IncreaseNET has been dedicated to strengthening collaboration, knowledge-sharing, and training within the European Medicines Regulatory Network (EMRN). Over the past year, the project […]

The CHESSMEN project has reached month 24.  A summary of the main activities carried out in 2024 can be found at this link.

On January 30 2025 IncreaseNET 2025 Assessors Forum: Enhancing NCAs Expertise gathered 180 participants, both in-person and online, from 25 EU/EEA countries, Ukraine, as well as representatives from the European […]

CHESSMEN Multi-stakeholder Workshop confirms that key stakeholders in shortage management agree on strengthening collaboration on all levels. JAZMP, lead of the Work package 6 in the Joint Action Coordination and […]

The Joint Action on Coordination and Harmonisation of the Existing Systems against Shortages of Medicines – European Network (CHESSMEN) invites you to the CHESSMEN Multi-stakeholder Workshop on 27 November 2024 […]

Please be informed that the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) is introducing electronic delivery of issued documents through the new system for […]

In relation to Commission Implementing Regulation (EU) 2024/2174 of 2 September 2024 laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council […]